F. Porreca - Concepedia

Concepedia

Author

F. Porreca

University of Arizona

Also Known As

F Porreca, F. Porreca, Frank Porreca, Porreca, F.

31

Publications

1.2K

Citations

14

H-Index

32

Concepts

All Affiliations

University of Arizona University of Minnesota

FP

About

F. Porreca is an author at University of Arizona specializing in neuropharmacology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	671
2	Health Sciences	5	5	497
3	Anesthesia	2	2	319
4	Social Sciences	1	1	153
5	Immunology	1	1	21

F. Porreca

×

14

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. Peter J. Horan, J. Andrew Taylor, Henry I. Yamamura, Journal of Pharmacology and Experimental Therapeutics	1992	215
Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5] enkephalin in the mouse F. Porreca, Julius S. Heyman, Henry I. Mosberg, Pain Delta ReceptorsPain MedicineMolecular PainPharmacotherapyExperimental Pharmacology	1988	166
Enhanced Evoked Excitatory Transmitter Release in Experimental Neuropathy Requires Descending Facilitation Luis R. Gardell, Todd W. Vanderah, Shannon Elizabeth Gardell, Journal of Neuroscience Peripheral Nerve InjuryPain MedicineNeuromodulation TherapiesNeuropathic PainMolecular Pain	2003	153
Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury F. Porreca, QingBo Tang, Di Bian, Brain Research Pain MedicineLumbar Spinal CordNeuropathic PainMolecular PainSpinal Disorder	1998	132
Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice Edward J. Bilsky, Charles E. Inturrisi, Wolfgang Sadée, Pain Opioid EpidemicPain DisordersPain MedicineNon-competitive Nmda AntagonistsMolecular Pain	1996	113
Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration. Steven Weber, D L Greene, Victor J. Hruby, Journal of Pharmacology and Experimental Therapeutics	1992	79
Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and sub-additivity Peter J. Horan, Ronald J. Tallarida, Ronald C. Haaseth, Life Sciences Molecular PharmacologyHealth SciencesPain MedicineAddictionMedicine	1992	64
Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. F. Porreca, Julius S. Heyman, Henry I. Mosberg, Journal of Pharmacology and Experimental Therapeutics	1987	44
Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. Russell J. Sheldon, L. Nunan, F. Porreca Journal of Pharmacology and Experimental Therapeutics	1987	40
Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. Russell J. Sheldon, L. Nunan, F. Porreca Journal of Pharmacology and Experimental Therapeutics	1989	40

Page 1